| Patent application number | Description | Published |
|---|
| 20080207904 | Imatinib base, and imatinib mesylate and processes for preparation thereof - The present invention provides crystalline forms of imatinib base, imatinib base free of desmethyl imatinib, and imatinib mesylate free of desmethyl imatinib mesylate, processes of their preparation and pharmaceutical compositions of imatinib mesylate. | 08-28-2008 |
| 20080214846 | Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof - Provided are darifenacin hydrobromide free of oxidized darifenacin, and processes for the preparation thereof. | 09-04-2008 |
| 20080216562 | Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof - Provided are darifenacin hydrobromide free of oxidized darifenacin, and processes for the preparation thereof. | 09-11-2008 |
| 20080221338 | Processes for preparing darifenacin hydrobromide - The invention encompasses processes for the preparation of darifenacin hydrobromide. | 09-11-2008 |
| 20080269503 | Processes for preparing darifenacin hydrobromide - The invention encompasses processes for the preparation of darifenacin hydrobromide. | 10-30-2008 |
| 20080269504 | Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof - Provided are darifenacin hydrobromide free of oxidized darifenacin, and processes for the preparation thereof. | 10-30-2008 |
| 20080269505 | Processes for preparing darifenacin hydrobromide - The invention encompasses processes for the preparation of darifenacin hydrobromide. | 10-30-2008 |
| 20090156831 | PROCESSES FOR PREPARING DARIFENACIN HYDROBROMIDE - The invention encompasses processes for the preparation of darifenacin hydrobromide. | 06-18-2009 |
| 20090192200 | POLYMORPHS OF SORAFENIB TOSYLATE AND SORAFENIB HEMI-TOSYLATE, AND PROCESSES FOR PREPARATION THEREOF - Provided are sorafenib hemi-tosylate, polymorphs thereof, polymorphs of sorafenib tosylate, preparation thereof and pharmaceutical compositions thereof. | 07-30-2009 |
| 20090247767 | PROCESSES FOR PREPARING SUNITINIB AND SALTS THEREOF - Methods for preparing sunitinib or salts thereof are described using novel intermediates and chemical pathways. One such intermediate is: | 10-01-2009 |
| 20090253913 | Process for the preparation of sorafenib and salts thereof - Methods for the synthesis of the N-carbamoyl imidazole (I) and its 1:1 adduct with imidazole are provided. Methods for the preparation of these crystalline intermediates in a high state of purity are also provided. These intermediates react cleanly under mild conditions to produce sorafenib in high yield and purity, without generating difficult-to-remove impurities. | 10-08-2009 |
| 20100160646 | PROCESSES FOR PREPARING SUNITINIB AND SALTS THEREOF - Methods for preparing sunitinib or salts thereof are described using novel intermediates and chemical pathways. One such intermediate is: | 06-24-2010 |
| 20110009596 | PROCESS FOR THE PREPARATION OF N-PROTECTED-DECYLAMINOETHANAL - Compounds useful in the preparation of telavancin, for example, were prepared. These compounds include decylaminoethanal dialkyl acetals and N-protected decylaminoethanal dialkyl acetals, imidazolidine derivatives, and N-protected-decylaminoethanal. | 01-13-2011 |
